TrialThe Journal of allergy and clinical immunology2010

Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome.

Florence Roufosse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.